Molecular biology methods can detect kidney cancer-related markers in urine or blood, such as DNA microsatellite alterations [21], VHL gene mutations or hypermethylation, renal cell carcinoma-specific proteins such as CA-9 expression, and upregulation of angiogenic factors such as VEGF expression [22]. This evidence concerns the gene VHL and hereditary clear cell renal cell carcinoma.